Skip to content

Effects Of Muscle Energy Technique Versus Mobilization

Effects Of Muscle Energy Technique Versus Mobilization On Pain And Disability In Post-Partum Females With Sacroiliac Joint Dysfunction.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04790500
Enrollment
50
Registered
2021-03-10
Start date
2020-10-14
Completion date
2021-08-20
Last updated
2021-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sacroiliac Joint Dysfunction

Keywords

Mobilization, Muscle energy technique, Postpartum, Sacroiliac joint pain

Brief summary

The aim is to describe the severity of pain in postpartum female and management of sacroiliac joint pain and disability and define the effects of manual therapy on sacroiliac joint dysfunction and pain

Detailed description

The aim is to describe the severity of pain in postpartum female and management of sacroiliac joint pain and disability and define the effects of manual therapy on sacroiliac joint dysfunction and pain in postpartum females and to check whether the amount of gaining range of movement is similar among postpartum female undergoing with mobilization therapy and with muscle energy technique.

Interventions

OTHERmobilization technique

Mobilization of sacroiliac joint which will increase the range of motion and reduction in pain and improvement in functional limitation.

OTHERmuscle energy technique

Muscle energy technique it is known as active muscular relaxation technique. It helps in lengthening the shorten muscle and increasing range of restricted muscles

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* 20-40 year having unilateral back pain around or on sacral sulcus, * Positive posterior pain provocation test for Sacroiliac joint dysfunction, * Low back pain within six weeks of delivery * Pain while sitting down, lying on the ipsilateral side of pain, or climbing stairs. * Local tenderness of the posterior aspect of the sacroiliac joint * Pain is usually localized over the buttock. * Sharp, stabbing, and/or shooting pain which extends down the posterior thigh usually not past the knee. * C-section

Exclusion criteria

* Neurological deficit * Spinal tumors * Scoliosis, * Underwent spinal surgery and prolapsed * Intervertebral disc with or without radiculopathy

Design outcomes

Primary

MeasureTime frameDescription
Numeric pain rating scale4th weeko The 11-point (numeric pain rating scale) NPRS will use to capture the patient's level of pain. The scale is anchored on the left with the phrase ''no pain'' and on the right with the phrase ''worst imaginable pain.'' Patients rate their current level of pain and their worst and least amount of pain in the last 24 hours. The average of the 3 ratings or any single rating may be used to represent the patient's level of pain. Numeric pain scales have been shown to be reliable and valid. The reliability of numeric pain rating scale is 0.74
Modified Oswestry disability index4th weekIt is a self-report questionnaire of a patient's perceived disability based on 10 areas of pain and daily activities (pain intensity, personal hygiene, lifting, walking, sitting, standing, sleeping, sexual activity, social activity and travelling). Each section is scored on a6-point scale (0-5), with 0 representing no limitation and 5 representing maximal limitation. The subscales combined add up to a total maximal score of 50. The score is then doubled and interpreted as a percentage of the patient-perceived disability (the higher the score, the greater the disability). In cases where patients did not answer all the 10 sections, the sum score of the answered sections were divided by the number of completed sections. The reliability of modified oswestry disability index is 0.88.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026